(R)-CR8 trihydrochloride

Catalog No.E0647 Batch:E064701

Print

Technical Data

Formula

C24H29N7O.3ClH

Molecular Weight 540.92 CAS No. 1786438-30-9
Solubility (25°C)* In vitro DMSO 100 mg/mL (184.87 mM)
Water 100 mg/mL (184.87 mM)
Ethanol 25 mg/mL (46.21 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description (R)-CR8 trihydrochloride, one of CR8 isomers, is a potent inhibitor CDK1/2/5/7/9 with antiproliferative effect and proapoptotic effect on CML cell lines.
Targets
CDK1 [1] CDK2 [1] CDK5 [1] CDK7 [1] CDK9 [1]
In vitro

(R)-CR8 trihydrochloride (0.1-100 μM) is a potent inducer of apoptotic cell death with an IC50 of 0.49 μM for SH-SY5Y cell line. (R)-CR8 trihydrochloride (0.25-10 μM) induces a dose-dependent induction of poly-(ADP-ribose)polymerase (PARP) cleavage.[2]

In vivo

(R)-CR8 trihydrochloride treatment attenuates sensorimotor and cognitive deficits, alleviates depressive-like symptoms, and decreased lesion volume in lateral fluid percussion-induced traumatic brain injury rats.[3]

Protocol (from reference)

Cell Assay:

[2]

  • Cell lines

    SH-SY5Y cell line

  • Concentrations

    0.1-100 μM, 0.25-10 μM

  • Incubation Time

    48 h

  • Method

    (R)-CR8 trihydrochloride treatment is performed on exponentially growing cultures(0.1-100 μM or 0.25-10 μM; 48h). Control experiments are carried also using appropriate dilutions of DMSO. Cell viability is determined by measuring the reduction of MTS. Cell death is determined by measuring the level of LDH activity released upon cell lysis.The expression level of PARP is tested by western blotting.

Animal Study:

[3]

  • Animal Models

    lateral fluid percussion-induced traumatic brain injury rats(male; Sprague-Dawley)

  • Dosages

    5 mg/Kg

  • Administration

    i.p.

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.